Bacans Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.48 M
as on 11-12-2024
- Revenue 3.53%
(FY 2020)
- Profit -0.21%
(FY 2020)
- Ebitda -3.76%
(FY 2020)
- Net Worth 16.87%
(FY 2020)
- Total Assets 3.28%
(FY 2020)
About Bacans Biotech
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.48 M.
Anshu Tiwari and Dwiz Kumar serve as directors at the Company.
- CIN/LLPIN
U52609DL2012PTC242466
- Company No.
242466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bacans Biotech Private Limited offer?
Bacans Biotech Private Limited offers a wide range of products and services, including Multivitamin Tablets & Capsules, Antioxidant Capsule, Multivitamin Syrup & Drops, Vitamin B Complex Syrup, Pharmaceutical Syrup, Dry Syrups, Allopathic Cough Syrup, Dextromethorphan Cough Syrup, Antibiotic Tablets & Capsules, Cefixime Tablet.
Who are the key members and board of directors at Bacans Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshu Tiwari  | Director | 18-Sep-2012 | Current |
| Dwiz Kumar | Director | 18-Sep-2012 | Current |
Financial Performance of Bacans Biotech.
Bacans Biotech Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.53% increase. The company also saw a slight decrease in profitability, with a 0.21% decrease in profit. The company's net worth Soared by an impressive increase of 16.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bacans Biotech?
In 2017, Bacans Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
J&K Bank Creation Date: 27 Jan 2016 | ₹0.48 M | Open |
How Many Employees Work at Bacans Biotech?
Unlock and access historical data on people associated with Bacans Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bacans Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bacans Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
